1. "2019"
Formats
  1. Journal Article (2144)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2450)
  2. Solid Tumor Oncology Division (1408)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (937)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5611)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5611)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A multicenter, randomized phase III study of asciminib (ABL001) versus bosutinib in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) previously treated with ≥2 tyrosine kinase inhibitors (TKIs)
    Meeting Abstract

    Mauro, M. J.; Hochhaus, A.; Boquimpani, C.; Minami, Y.; Allepuz, A.; Polydoros, F.; Bédoucha, V.; Aimone, P.; Réa, D.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • TBCRC 030: A randomized phase II study of preoperative cisplatin versus paclitaxel in TNBC-Evaluating the homologous recombination deficiency (HRD) biomarker
    Meeting Abstract

    Mayer, E. L.; Abramson, V. G.; Jankowitz, R. C.; Falkson, C. I.; Marcom, P. K.; Traina, T. A.; Carey, L. A.; Rimawi, M. F.; Specht, J. M.; Miller, K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Long-term symptom burden and quality of life in metastatic melanoma patients treated with checkpoint inhibitors
    Meeting Abstract

    Mamoor, M.; Lavery, J. A.; Sidlow, R.; Rogak, L. J.; Thom, B.; Khan, N.; Baxi, S. S.; Wolchok, J. D.; Postow, M. A.; Korenstein, D.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC)
    Meeting Abstract

    Mamounas, E. P.; Bandos, H.; White, J. R.; Julian, T. B.; Khan, A. J.; Shaitelman, S. F.; Torres, M. A.; Vicini, F.; Ganz, P. A.; McCloskey, S. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastroesophageal junction cancer (mGEJC): Subgroup analysis from TAGS
    Meeting Abstract

    Mansoor, W.; Arkenau, H. T.; Alsina, M.; Shitara, K.; Tejani, M. A.; Thuss-Patience, P. C.; Cuffe, S.; Dvorkin, M.; Park, D.; Ando, T.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Evaluating gender as a predictive marker for response to bevacizuamb (Bev) in metastatic colorectal carcinoma (mCRC): Pooled analysis of 3369 patients (pts) in the ARCAD database
    Meeting Abstract

    Margalit, O.; Harmsen, W. S.; Shacham-Shmueli, E.; Petersen, M.; Boursi, B.; Saltz, L. B.; Adams, R.; Maughan, T.; Douillard, J. Y.; Van Cutsem, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Acupuncture versus cognitive behavioral therapy for cognitive impairment in cancer survivors with insomnia: Implications for personalized medicine
    Meeting Abstract

    Mao, J. J.; Liou, K.; Root, J.; Li, Q. S.; Bao, T.; Garland, S. N.; Ahles, T.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase 3 trial evaluating efficacy and safety of lenvatinib in combination with pembrolizumab in patients with advanced endometrial cancer
    Meeting Abstract

    Makker, V.; Herraez, A. C.; Aghajanian, C.; Fujiwara, K.; Pignata, S.; Penson, R. T.; Dutcus, C. E.; Guo, M.; Dutta, L.; Orlowski, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical significance of circulating tumor cells (CTCs) in hormone receptor-positive (HR+) metastatic breast cancer (MBC) patients (pts) receiving letrozole (Let) or Let plus bevacizumab (Bev): CALGB 40503 (Alliance)
    Meeting Abstract

    Magbanua, M. J. M.; Savenkov, O. O.; Asmus, E.; Ballman, K. V.; Scott, J. H.; Park, J.; Dickler, M. N.; Partridge, A. H.; Carey, L. A.; Winer, E. P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
    Meeting Abstract

    Mailankody, S.; Salcedo, M.; Tavitian, E.; Korde, N.; Lendvai, N.; Hassoun, H.; Lesokhin, A. M.; Lahoud, O. B.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save